Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism

Author(s): Amjad A. Khan*, Khaled S. Allemailem, Fahad A. Alhumaydhi, Sivakumar J.T. Gowder and Arshad H. Rahmani

Volume 20, Issue 6, 2020

Page: [855 - 868] Pages: 14

DOI: 10.2174/1871530320666191230141110

Price: $65

Abstract

Background: Lactate dehydrogenase (LDH) is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate. The five isoforms of this enzyme, formed from two subunits, vary in isoelectric points and these isoforms have different substrate affinity, inhibition constants and electrophoretic mobility. These diverse biochemical properties play a key role in its cellular, tissue and organ specificity. Though LDH is predominantly present in the cytoplasm, it has a multi-organellar location as well.

Objective: The primary objective of this review article is to provide an update in parallel, the previous and recent biochemical views and its clinical significance in different diseases.

Methods: With the help of certain inhibitors, its active site three-dimensional view, reactions mechanisms and metabolic pathways have been sorted out to a greater extent. Overexpression of LDH in different cancers plays a principal role in anaerobic cellular metabolism, hence several inhibitors have been designed to employ as novel anticancer agents.

Discussion: LDH performs a very important role in overall body metabolism and some signals can induce isoenzyme switching under certain circumstances, ensuring that the tissues consistently maintain adequate ATP supply. This enzyme also experiences some posttranslational modifications, to have diversified metabolic roles. Different toxicological and pathological complications damage various organs, which ultimately result in leakage of this enzyme in serum. Hence, unusual LDH isoform level in serum serves as a significant biomarker of different diseases.

Conclusion: LDH is an important diagnostic biomarker for some common diseases like cancer, thyroid disorders, tuberculosis, etc. In general, LDH plays a key role in the clinical diagnosis of various common and rare diseases, as this enzyme has a prominent role in active metabolism.

Keywords: Lactate dehydrogenase, Isoenzymes, isoenzyme switching; enzyme kinetics, post-translational modifications, enzyme inhibitors, clinical significance.

« Previous Next »
Graphical Abstract

[1]
Younus, H. Oxidoreductases: Overview and Practical Applications. Biocatalysis; Springer: Cham, 2019, pp. 39-55.
[2]
Ahmed Laskar, A.; Younus, H. Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis. Drug Metab. Rev., 2019, 51(1), 42-64.
[http://dx.doi.org/10.1080/03602532.2018.1555587]
[3]
Shi, Y.; Pinto, B.M. Human lactate dehydrogenase a inhibitors: A molecular dynamics investigation. PLoS One, 2014, 9(1)e86365
[http://dx.doi.org/10.1371/journal.pone.0086365]
[4]
Augoff, K.; Hryniewicz-Jankowska, A.; Tabola, R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett., 2015, 358(1), 1-7.
[http://dx.doi.org/10.1016/j.canlet.2014.12.035]
[5]
Kopperschläger, G.; Kirchberger, J. Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme. J. Chromatogr. B Biomed. Appl., 1996, 684(1-2), 25-49.
[http://dx.doi.org/10.1016/0378-4347(96)00133-8]
[6]
Drent, M.; Cobben, N.A.M.; Henderson, R.F.; Wouters, E.F.M.; van Dieijen-Visser, M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur. Respir. J., 1996, 9(8), 1736-1742.
[http://dx.doi.org/10.1183/09031936.96.09081736]
[7]
Cattaneo, A.; Biocca, S.; Corvaja, N.; Calissano, P. Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties. Exp. Cell Res., 1985, 161(1), 130-140.
[http://dx.doi.org/10.1016/0014-4827(85)90497-5]
[8]
Hashimoto, T.; Hussien, R.; Brooks, G.A. Colocalization of MCT1, CD147, and LDH in mitochondrial inner membrane of L6 muscle cells: evidence of a mitochondrial lactate oxidation complex. Am. J. Physiol. Endocrinol. Metab., 2006, 290(6), E1237-E1244.
[http://dx.doi.org/10.1152/ajpendo.00594.2005]
[9]
Lemire, J.; Mailloux, R.J.; Appanna, V.D. Mitochondrial lactate dehydrogenase is involved in oxidative-energy metabolism in human astrocytoma cells (CCF-STTG1). PLoS One, 2008, 3(2)e1550
[http://dx.doi.org/10.1371/journal.pone.0001550]
[10]
Zhong, X.H.; Howard, B.D. Phosphotyrosine-containing lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells. Mol. Cell. Biol., 1990, 10(2), 770-776.
[http://dx.doi.org/10.1128/MCB.10.2.770]
[11]
Cook, W.J.; Senkovich, O.; Hernandez, A.; Speed, H.; Chattopadhyay, D. Biochemical and structural characterization of Cryptosporidium parvum Lactate dehydrogenase. Int. J. Biol. Macromol., 2015, 74, 608-619.
[http://dx.doi.org/10.1016/j.ijbiomac.2014.12.019]
[12]
Krieg, A.F.; Rosenblum, L.J.; Henry, J.B. Lactate dehydrogenase isoenzymes a comparison of pyruvate-to-lactate and lactate-to-pyruvate assays. Clin. Chem., 1967, 13(3), 196-203.
[13]
Lott, J.A.; Memensanszky, E. Lactate dehydrogenase.Clinical Enzymology a case oriented approach; Lott, J.A; Wolf, P.L., Ed.; , 1987, pp. 213-244.
[14]
Moss, D.W.; Henderson, A.R. , 1986.
[15]
Richterich, R.; Schafroth, P.; Aebi, H. A study of lactic dehydrogenase isoenzyme pattern of human tissues by adsorption-elution on Sephadex-DEAE. Clin. Chim. Acta, 1963, 8, 178-192.
[http://dx.doi.org/10.1016/0009-8981(63)90155-4]
[16]
Wroblewski, F.; Gregory, K.F. Lactic dehydrogenase isozymes and their distribution in normal tissues and plasma and in disease states. Ann. N. Y. Acad. Sci., 1961, 94, 912-932.
[http://dx.doi.org/10.1111/j.1749-6632.1961.tb35584.x]
[17]
Roman, W. Quantitative estimation of lactate dehydrogenase isoenzymes in serum. Review of methods and distribution in human tissues. Enzymologia, 1969, •••, 36189-36219.
[18]
Yu, Y.; Deck, J.A.; Hunsaker, L.A.; Deck, L.M.; Royer, R.E.; Goldberg, E.; Vander Jagt, D.L. Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4. Biochem. Pharmacol., 2001, 62(1), 81-89.
[http://dx.doi.org/10.1016/S0006-2952(01)00636-0]
[19]
Whitt, G.S. Genetic, developmental and evolutionary aspects of the lactate dehydrogenase isozyme system. Cell Biochem. Funct., 1984, 2(3), 134-139.
[http://dx.doi.org/10.1002/cbf.290020303]
[20]
Wieme, R.J.; Herpol, J.E. Origin of the lactate dehydrogenase isoenzyme pattern found in the serum of patients having primary muscular dystrophy. Nature, 1962, 194, 287-288.
[http://dx.doi.org/10.1038/194287b0]
[21]
Fine, I.; Kaplan, N.O.; Kuftinec, D.J. Developmental changes of mammalian lactic dehydrogenase. Exp Zool, 1963, 152, 116-121.
[22]
Instruments, B. Lactate dehydrogenase and isoenzymes., 1993.
[23]
Everse, J.; Kaplan, N.O. , 1975.
[24]
Dawson, D.M.; Goodfriend, T.L.; Kaplan, N.O. Lactic dehydrogenases: functions of the two types. Science, 1964, 143(3609), 929-933.
[http://dx.doi.org/10.1126/science.143.3609.929]
[25]
Sharma, P.R.; Jain, S.; Bamezai, R.N.K.; Tiwari, P.K. Utility of serum LDH isoforms in the assessment of mycobacterium tuberculosis induced pathology in TB patients of Sahariya tribe. Indian J. Clin. Biochem., 2010, 25(1), 57-63.
[http://dx.doi.org/10.1007/s12291-010-0012-3]
[26]
Kayser, G.; Kassem, A.; Sienel, W.; Schulte-Uentrop, L.; Mattern, D.; Aumann, K.; Stickeler, E.; Werner, M.; Passlick, B.; zur Hausen, A. Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Diagn. Pathol., 2010, 5, 22.
[http://dx.doi.org/10.1186/1746-1596-5-22]
[27]
Grosse, F.; Nasheuer, H.P.; Scholtissek, S.; Schomburg, U. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex. Eur. J. Biochem., 1986, 160(3), 459-467.
[http://dx.doi.org/10.1111/j.1432-1033.1986.tb10062.x]
[28]
Blanco, A.; Zinkham, W.H. Lactate dehydrogenases in human testes. Science, 1963, 139(3555), 601-602.
[http://dx.doi.org/10.1126/science.139.3555.601]
[29]
Goldberg, E. Lactate Dehydrogenases and malate dehydrogenases in sperm: studied by polyacrylamide gel electrophoresis. Ann. N. Y. Acad. Sci., 1964, 121, 560-570.
[http://dx.doi.org/10.1111/j.1749-6632.1964.tb14226.x]
[30]
Coonrod, S.; Vitale, A.; Duan, C.; Bristol-Gould, S.; Herr, J.; Goldberg, E. Testis-specific lactate dehydrogenase (LDH-C4; Ldh3) in murine oocytes and preimplantation embryos. J. Androl., 2006, 27(4), 502-509.
[http://dx.doi.org/10.2164/jandrol.05185]
[31]
Geyer, H.; Riebschläger, M. Effect of pregnancy on cytoplasmic and mitochondrial enzymes in human and animal myometrium. Acta Endocrinol. (Copenh.), 1974, 77(2), 368-379.
[http://dx.doi.org/10.1530/acta.0.0770368]
[32]
Makkonen, M.; Puhakainen, E.; Hänninen, O.; Castrén, O. Lactate dehydrogenase isoenzymes in human myometrium during pregnancy and labor. Acta Obstet. Gynecol. Scand., 1982, 61(1), 35-37.
[http://dx.doi.org/10.3109/00016348209156948]
[33]
Makkonen, M. Myometrial energy metabolism during pregnancy and normal and dysfunctional labor. Acta Obstet. Gynecol. Scand. Suppl., 1977, 71, 1-68.
[http://dx.doi.org/10.3109/00016347709156464]
[34]
Hawkins, D.F.; Whyley, G.A. The nature of the lactate dehydrogenase isoenzymes in human placenta and related tissues. Clin. Chim. Acta, 1966, 13(6), 713-719.
[http://dx.doi.org/10.1016/0009-8981(66)90136-7]
[35]
Meade, B.W.; Rosalki, S.B. The origin of increased maternal serum enzyme activity in pregnancy and labor. J. Obstet. Gynaecol. Br. Commonw., 1963, 70, 862-868.
[http://dx.doi.org/10.1111/j.1471-0528.1963.tb04992.x]
[36]
Parratt, J.; Taggart, M.; Wray, S. Abolition of contractions in the myometrium by acidification in vitro. Lancet, 1994, 344(8924), 717-718.
[http://dx.doi.org/10.1016/S0140-6736(94)92209-8]
[37]
Parratt, J.R.; Taggart, M.J.; Wray, S. Functional effects of intracellular pH alteration in the human uterus: Simultaneous measurements of pH and force. J. Reprod. Fertil., 1995, 105(1), 71-75.
[http://dx.doi.org/10.1530/jrf.0.1050071]
[38]
Pierce, S.J.; Kupittayanant, S.; Shmygol, T.; Wray, S. The effects of pH change on Ca(++) signaling and force in pregnant human myometrium. Am. J. Obstet. Gynecol., 2003, 188(4), 1031-1038.
[http://dx.doi.org/10.1067/mob.2003.229]
[39]
Monir-Bishty, E.; Pierce, S.J.; Kupittayanant, S.; Shmygol, A.; Wray, S. The effects of metabolic inhibition on intracellular calcium and contractility of human myometrium. BJOG, 2003, 110(12), 1050-1056.
[http://dx.doi.org/10.1111/j.1471-0528.2003.03103.x]
[40]
Nissen, C.; Schousboe, A. Activity and isoenzyme pattern of lactate dehydrogenase in astroblasts cultured from brains of newborn mice. J. Neurochem., 1979, 32(6), 1787-1792.
[http://dx.doi.org/10.1111/j.1471-4159.1979.tb02292.x]
[41]
Cahn, R.D.; Zwilling, E.; Kaplan, N.O.; Levine, L. Nature and Development of Lactic Dehydrogenases: The two major types of this enzyme form molecular hybrids which change in makeup during development. Science, 1962, 136(3520), 962-969.
[http://dx.doi.org/10.1126/science.136.3520.962]
[42]
Bittar, P.G.; Charnay, Y.; Pellerin, L.; Bouras, C.; Magistretti, P.J. Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J. Cereb. Blood Flow Metab., 1996, 16(6), 1079-1089.
[http://dx.doi.org/10.1097/00004647-199611000-00001]
[43]
Griffin, H.G.; Swindell, S.R.; Gasson, M.J. Cloning and sequence analysis of the gene encoding L-lactate dehydrogenase from Lactococcus lactis: evolutionary relationships between 21 different LDH enzymes. Gene, 1992, 122(1), 193-197.
[http://dx.doi.org/10.1016/0378-1119(92)90049-U]
[44]
Gerhardt-Hansen, W. Lactate dehydrogenase isoenzymes in the central nervous system. Dan. Med. Bull., 1968, 15, 1-112.
[45]
Nitisewojo, P.; Hultin, H.O. A comparison of some kinetic properties of soluble and bound lactate dehydrogenase isoenzymes at different temperatures. Eur. J. Biochem., 1976, 67(1), 87-94.
[http://dx.doi.org/10.1111/j.1432-1033.1976.tb10636.x]
[46]
Stambaugh, R.; Post, D. Substrate and product inhibition of rabbit muscle lactic dehydrogenase heart (H4) and muscle (M4) isozymes. J. Biol. Chem., 1966, 241(7), 1462-1467.
[47]
Quistorff, B.; Grunnet, N. The isoenzyme pattern of LDH does not play a physiological role; except perhaps during fast transitions in energy metabolism. Aging (Albany NY), 2011, 3(5), 457-460.
[http://dx.doi.org/10.18632/aging.100329]
[48]
Hohlbrook, J.J.; Liljas, A.; Steindel, S.J.; Rossmann, M.G. Lactate Dehydrogenase.The Enzymes, 3rd ed; Boyer, P.D., Ed.; Part A, Academic Press New York, 1975, Vol. XI, p. 191.
[49]
Clarke, A.R.; Wilks, H.M.; Barstow, D.A.; Atkinson, T.; Chia, W.N.; Holbrook, J.J. An investigation of the contribution made by the carboxylate group of an active site histidine-aspartate couple to binding and catalysis in lactate dehydrogenase. Biochemistry, 1988, 27(5), 1617-1622.
[http://dx.doi.org/10.1021/bi00405a034]
[50]
Read, J.A.; Winter, V.J.; Eszes, C.M.; Sessions, R.B.; Brady, R.L. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins, 2001, 43(2), 175-185.
[http://dx.doi.org/10.1002/1097-0134(20010501)43:2<175:AID-PROT1029>3.0.CO;2-#]
[51]
Sharma, P.R.; Jain, S.; Tiwari, P.K. Elevated level of serum LDH2 and LDH3 in sputum three positive TB patients of Sahariya tribe: a preliminary study. Clin. Biochem., 2007, 40(18), 1414-1419.
[http://dx.doi.org/10.1016/j.clinbiochem.2007.04.024]
[52]
Clarke, A.R.; Wigley, D.B.; Chia, W.N.; Barstow, D.; Atkinson, T.; Holbrook, J.J. Site-directed mutagenesis reveals role of mobile arginine residue in lactate dehydrogenase catalysis. Nature, 1986, 324(6098), 699-702.
[http://dx.doi.org/10.1038/324699a0]
[53]
Anderson, V.E.; LaReau, R.D. Hydride transfer catalyzed by lactate dehydrogenase displays absolute stereospecificity at C4 of the nicotinamide ring. J. Am. Chem. Soc., 1988, 110, 3695-3697.
[http://dx.doi.org/10.1021/ja00219a074]
[54]
Adams, M.J.; Buehner, M.; Chandrasekhar, K.; Ford, G.C.; Hackert, M.L.; Liljas, A.; Rossmann, M.G.; Smiley, I.E.; Allison, W.S.; Everse, J.; Kaplan, N.O.; Taylor, S.S. Structure-function relationships in lactate dehydrogenase. Proc. Natl. Acad. Sci. USA, 1973, 70(7), 1968-1972.
[http://dx.doi.org/10.1073/pnas.70.7.1968]
[55]
Clarke, A.R.; Atkinson, T.; Holbrook, J.J. From analysis to synthesis: new ligand binding sites on the lactate dehydrogenase framework. Part I. Trends Biochem. Sci., 1989, 14(3), 101-105.
[http://dx.doi.org/10.1016/0968-0004(89)90131-X]
[56]
Deng, H.; Zheng, J.; Burgner, J.; Callender, R. Molecular properties of pyruvate bound to lactate dehydrogenase: a Raman spectroscopic study. Proc. Natl. Acad. Sci. USA, 1989, 86(12), 4484-4488.
[http://dx.doi.org/10.1073/pnas.86.12.4484]
[57]
Ruobing, H.; Zhida, C.; Xianghui, Y.; Jiang, B.; Guangxian, X. Catalytic reaction mechanism of L-lactate dehydrogenase: an ab initio study. Sci. China, 2000, 43(6), 587-599. [Series B].
[58]
Deng, H.; Zheng, J.; Clarke, A.; Holbrook, J.J.; Callender, R.; Burgner, J.W., II Source of catalysis in the lactate dehydrogenase system. Ground-state interactions in the enzyme-substrate complex. Biochemistry, 1994, 33(8), 2297-2305.
[http://dx.doi.org/10.1021/bi00174a042]
[59]
Eventoff, W.; Rossmann, M.G.; Taylor, S.S.; Torff, H.J.; Meyer, H.; Keil, W.; Kiltz, H.H.; Kiltz, H-H. Structural adaptations of lactate dehydrogenase isozymes. Proc. Natl. Acad. Sci. USA, 1977, 74(7), 2677-2681.
[http://dx.doi.org/10.1073/pnas.74.7.2677]
[60]
McPherson, A., Jr Interaction of lactate dehydrogenase with its coenzyme, nicotinamide-adenine dinucleotide. J. Mol. Biol., 1970, 51(1), 39-46.
[http://dx.doi.org/10.1016/0022-2836(70)90268-8]
[61]
Sugrobova, N.P.; Kurganov, B.I.; Yukovlev, V.A. Biokhimiya, 1975, 40, 281-289.
[62]
Everse, J.; Kaplan, N. 0. Advances in Enzymology; Meister, A., Ed.; John Wiley and Sons: New York, 1973, pp. 61-134.
[63]
Davies, D.D.; Davies, S. Purification and properties of L(+)-lactate dehydrogenase from potato tubers. Biochem. J., 1972, 129(4), 831-839.
[64]
Bergmeyer, H.U. , 1983.
[65]
Götz, F.; Schleifer, K.H. Biochemical properties and the physiological role of the fructose-1,6-bisphosphate activated L-lactate dehydrogenase from Staphylococcus epidermidis. Eur. J. Biochem., 1978, 90(3), 555-561.
[http://dx.doi.org/10.1111/j.1432-1033.1978.tb12635.x]
[66]
Hardman, M.J.; Crow, V.L.; Cruickshank, D.S.; Pritchard, G.G. Kinetics of activation of L-lactate dehydrogenase from Streptococcus lactis by fructose 1,6-bisphosphate. Eur. J. Biochem., 1985, 146(1), 179-183.
[http://dx.doi.org/10.1111/j.1432-1033.1985.tb08636.x]
[67]
Gordon, G.L.; Doelle, H.W. Purification, properties and immunological relationship of L (+)-lactate dehydrogenase from Lactobacillus casei. Eur. J. Biochem., 1976, 67(2), 543-555.
[http://dx.doi.org/10.1111/j.1432-1033.1976.tb10720.x]
[68]
Williams, R.A.; Andrews, P. Purification of the fructose 1,6-bisphosphate-dependent lactate dehydrogenase from Streptococcus uberis and an investigation of its existence in different forms. Biochem. J., 1986, 236(3), 721-727.
[http://dx.doi.org/10.1042/bj2360721]
[69]
Markert, C.L. Lactate dehydrogenase. Biochemistry and function of lactate dehydrogenase. Cell Biochem. Funct., 1984, 2(3), 131-134.
[http://dx.doi.org/10.1002/cbf.290020302]
[70]
Goldberg, E. , 1975.
[71]
Wilkinson, J.H.; Withycombe, W.A. Organ specificity and lactate-dehydrogenase activity. Some properties of human spermatozoal lactate dehydrogenase. Biochem. J., 1965, 97(3), 663-668.
[72]
Granchi, C.; Roy, S.; Giacomelli, C.; Macchia, M.; Tuccinardi, T.; Martinelli, A.; Lanza, M.; Betti, L.; Giannaccini, G.; Lucacchini, A.; Funel, N.; León, L.G.; Giovannetti, E.; Peters, G.J.; Palchaudhuri, R.; Calvaresi, E.C.; Hergenrother, P.J.; Minutolo, F. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J. Med. Chem., 2011, 54(6), 1599-1612.
[http://dx.doi.org/10.1021/jm101007q]
[73]
Ward, R.A.; Brassington, C.; Breeze, A.L.; Caputo, A.; Critchlow, S.; Davies, G.; Goodwin, L.; Hassall, G.; Greenwood, R.; Holdgate, G.A.; Mrosek, M.; Norman, R.A.; Pearson, S.; Tart, J.; Tucker, J.A.; Vogtherr, M.; Whittaker, D.; Wingfield, J.; Winter, J.; Hudson, K. Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation. J. Med. Chem., 2012, 55(7), 3285-3306.
[http://dx.doi.org/10.1021/jm201734r]
[74]
Kohlmann, A.; Zech, S.G.; Li, F.; Zhou, T.; Squillace, R.M.; Commodore, L.; Greenfield, M.T.; Lu, X.; Miller, D.P.; Huang, W.S.; Qi, J.; Thomas, R.M.; Wang, Y.; Zhang, S.; Dodd, R.; Liu, S.; Xu, R.; Xu, Y.; Miret, J.J.; Rivera, V.; Clackson, T.; Shakespeare, W.C.; Zhu, X.; Dalgarno, D.C. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors. J. Med. Chem., 2013, 56(3), 1023-1040.
[http://dx.doi.org/10.1021/jm3014844]
[75]
Dragovich, P.S.; Fauber, B.P.; Boggs, J.; Chen, J.; Corson, L.B.; Ding, C.Z.; Eigenbrot, C.; Ge, H.; Giannetti, A.M.; Hunsaker, T.; Labadie, S.; Li, C.; Liu, Y.; Liu, Y.; Ma, S.; Malek, S.; Peterson, D.; Pitts, K.E.; Purkey, H.E.; Robarge, K.; Salphati, L.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wang, J.; Wei, B.; Xu, Q.; Yen, I.; Yue, Q.; Zhang, H.; Zhang, X.; Zhou, A. Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorg. Med. Chem. Lett., 2014, 24(16), 3764-3771.
[http://dx.doi.org/10.1016/j.bmcl.2014.06.076]
[76]
Fauber, B.P.; Dragovich, P.S.; Chen, J.; Corson, L.B.; Ding, C.Z.; Eigenbrot, C.; Giannetti, A.M.; Hunsaker, T.; Labadie, S.; Liu, Y.; Liu, Y.; Malek, S.; Peterson, D.; Pitts, K.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wang, J.; Wei, B.; Yen, I.; Yue, Q. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase. Bioorg. Med. Chem. Lett., 2013, 23(20), 5533-5539.
[http://dx.doi.org/10.1016/j.bmcl.2013.08.060]
[77]
Deck, L.M.; Royer, R.E.; Chamblee, B.B.; Hernandez, V.M.; Malone, R.R.; Torres, J.E.; Hunsaker, L.A.; Piper, R.C.; Makler, M.T.; Vander Jagt, D.L. Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J. Med. Chem., 1998, 41(20), 3879-3887.
[http://dx.doi.org/10.1021/jm980334n]
[78]
Maftouh, M.; Avan, A.; Sciarrillo, R.; Granchi, C.; Leon, L.G.; Rani, R.; Funel, N.; Smid, K.; Honeywell, R.; Boggi, U.; Minutolo, F.; Peters, G.J.; Giovannetti, E. Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. Br. J. Cancer, 2014, 110(1), 172-182.
[http://dx.doi.org/10.1038/bjc.2013.681]
[79]
Steinbiichel, A.; Schlegel, H.G. A multifunctional fermentative alcohol dehydrogenase from the strict aerobi Alcaligenes eutrophus: purification and properties. Eur. J. Biochem., 1983, 141, 555-564.
[http://dx.doi.org/10.1111/j.1432-1033.1984.tb08229.x]
[80]
Novoa, W.B.; Winer, A.D.; Glaid, A.J.; Schwert, G.W. Lactic dehydrogenase. V. Inhibition by oxamate and by oxalate. J. Biol. Chem., 1959, 234(5), 1143-1148.
[81]
Vassault, A. Lactate dehydrogenase UV-method with pyrurate and NADH., 1983.
[82]
Schomburg, D.; Stephan, D. , 1995.
[83]
Dando, C.; Schroeder, E.R.; Hunsaker, L.A.; Deck, L.M.; Royer, R.E.; Zhou, X.; Parmley, S.F.; Vander Jagt, D.L. The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum. Mol. Biochem. Parasitol., 2001, 118(1), 23-32.
[http://dx.doi.org/10.1016/S0166-6851(01)00360-7]
[84]
Keluskar, P.; Mohile, A.; Ingle, S. Inhibition kinetics of Plasmodium Lactate Dehydrogenase with herbal extracts suggest possible enzyme inhibitor molecular interaction. Malar. J., 2012, 11, 56.
[http://dx.doi.org/10.1186/1475-2875-11-S1-P56]
[85]
Royer, R.E.; Deck, L.M.; Campos, N.M.; Hunsaker, L.A.; Vander Jagt, D.L. Biologically active derivatives of gossypol: synthesis and antimalarial activities of peri-acylated gossylic nitriles. J. Med. Chem., 1986, 29(9), 1799-1801.
[http://dx.doi.org/10.1021/jm00159a043]
[86]
Dunn, C.R.; Banfield, M.J.; Barker, J.J.; Higham, C.W.; Moreton, K.M.; Turgut-Balik, D.; Brady, R.L.; Holbrook, J.J. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat. Struct. Biol., 1996, 3(11), 912-915.
[http://dx.doi.org/10.1038/nsb1196-912]
[87]
Sessions, R.B.; Dewar, V.; Clarke, A.R.; Holbrook, J.J. A model of Plasmodium falciparum lactate dehydrogenase and its implications for the design of improved antimalarials and the enhanced detection of parasitaemia. Protein Eng., 1997, 10(4), 301-306.
[http://dx.doi.org/10.1093/protein/10.4.301]
[88]
Winter, V.J.; Cameron, A.; Tranter, R.; Sessions, R.B.; Brady, R.L. Crystal structure of Plasmodium berghei lactate dehydrogenase indicates the unique structural differences of these enzymes are shared across the Plasmodium genus. Mol. Biochem. Parasitol., 2003, 131(1), 1-10.
[http://dx.doi.org/10.1016/S0166-6851(03)00170-1]
[89]
Farabegoli, F.; Vettraino, M.; Manerba, M.; Fiume, L.; Roberti, M.; Di Stefano, G. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. Eur. J. Pharm. Sci., 2012, 47(4), 729-738.
[http://dx.doi.org/10.1016/j.ejps.2012.08.012]
[90]
Billiard, J.; Dennison, J.B.; Briand, J.; Annan, R.S.; Chai, D.; Colón, M.; Dodson, C.S.; Gilbert, S.A.; Greshock, J.; Jing, J.; Lu, H.; McSurdy-Freed, J.E.; Orband-Miller, L.A.; Mills, G.B.; Quinn, C.J.; Schneck, J.L.; Scott, G.F.; Shaw, A.N.; Waitt, G.M.; Wooster, R.F.; Duffy, K.J. Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells. Cancer Metab., 2013, 1(1), 19.
[http://dx.doi.org/10.1186/2049-3002-1-19]
[91]
Sanders, G.T.; van der Neut, E.; van Straslen, J.P. Inhibition of LDH isoenzymes by sodium perchlorate evaluated. Clin. Chem., 1990, 36, 1964-1966.
[92]
Rosnowska, M.; Sawicki, Z.; Krawczyński, J. Inhibition of lactate dehydrogenase isoenzymes activity by potassium oxalate and urea in some liver diseases. Clin. Chim. Acta, 1968, 20(1), 7-10.
[http://dx.doi.org/10.1016/0009-8981(68)90376-8]
[93]
Zhao, Z.; Han, F.; Yang, S.; Wu, J.; Zhan, W. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway. Cancer Lett., 2015, 358(1), 17-26.
[http://dx.doi.org/10.1016/j.canlet.2014.11.046]
[94]
Fuery, C.J.; Attwood, P.V.; Withers, P.C.; Yancey, P.H.; Baldwin, J.; Guppy, M. Effects of urea on M4-lactate dehydrogenase from elasmobranchs and urea-accumulating Australian desert frogs. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 1997, 117(1), 143-150.
[http://dx.doi.org/10.1016/S0305-0491(96)00287-8]
[95]
Xue, J-J.; Chen, Q-Y.; Kong, M-Y.; Zhu, C-Y.; Gen, Z-R.; Wang, Z-L. Synthesis, cytotoxicity for mimics of catalase: inhibitors of lactate dehydrogenase and hypoxia inducible factor. Eur. J. Med. Chem., 2014, 80, 1-7.
[http://dx.doi.org/10.1016/j.ejmech.2014.04.035]
[96]
Steinbiichel, A.; Schlegel, H.G. NAD-linked l(+)-Lactate dehydrogenase from the strict aerobe Alcaligeneseutrophus. Eur. J. Biochem., 1983, 130, 321.
[http://dx.doi.org/10.1111/j.1432-1033.1983.tb07155.x]
[97]
Yao, K.; Wang, N.; Zhuang, J.; Yang, Z.; Ni, H.; Xu, Q.; Sun, C.; Bi, S. Studies on the effects of Al(III) on the lactate dehydrogenase activity by differential pulse voltammetry. Talanta, 2007, 73(3), 529-533.
[http://dx.doi.org/10.1016/j.talanta.2007.04.025]
[98]
Rupiani, S.; Buonfiglio, R.; Manerba, M.; Di Ianni, L.; Vettraino, M.; Giacomini, E.; Masetti, M.; Falchi, F.; Di Stefano, G.; Roberti, M.; Recanatini, M. Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors. Eur. J. Med. Chem., 2015, 101, 63-70.
[http://dx.doi.org/10.1016/j.ejmech.2015.06.028]
[99]
Bader, A.; Tuccinardi, T.; Granchi, C.; Martinelli, A.; Macchia, M.; Minutolo, F.; De Tommasi, N.; Braca, A. Phenylpropanoids and flavonoids from Phlomis kurdica as inhibitors of human lactate dehydrogenase. Phytochemistry, 2015, 116, 262-268.
[http://dx.doi.org/10.1016/j.phytochem.2015.03.007]
[100]
Labadie, S.; Dragovich, P.S.; Chen, J.; Fauber, B.P.; Boggs, J.; Corson, L.B.; Ding, C.Z.; Eigenbrot, C.; Ge, H.; Ho, Q.; Lai, K.W.; Ma, S.; Malek, S.; Peterson, D.; Purkey, H.E.; Robarge, K.; Salphati, L.; Sideris, S.; Ultsch, M.; VanderPorten, E.; Wei, B.; Xu, Q.; Yen, I.; Yue, Q.; Zhang, H.; Zhang, X.; Zhou, A. Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorg. Med. Chem. Lett., 2015, 25(1), 75-82.
[http://dx.doi.org/10.1016/j.bmcl.2014.11.008]
[101]
Fauber, B.P.; Dragovich, P.S.; Chen, J.; Corson, L.B.; Ding, C.Z.; Eigenbrot, C.; Labadie, S.; Malek, S.; Peterson, D.; Purkey, H.E.; Robarge, K.; Sideris, S.; Ultsch, M.; Wei, B.; Yen, I.; Yue, Q.; Zhou, A. Identification of 3,6-disubstituted dihydropyrones as inhibitors of human lactate dehydrogenase. Bioorg. Med. Chem. Lett., 2014, 24(24), 5683-5687.
[http://dx.doi.org/10.1016/j.bmcl.2014.10.067]
[102]
Grabowski, M.; Banecki, B.; Kadziński, L.; Jakóbkiewicz-Banecka, J.; Kaźmierkiewicz, R.; Gabig-Cimińska, M.; Węgrzyn, G.; Węgrzyn, A.; Banecka-Majkutewicz, Z. Genistein inhibits activities of methylenetetrahydrofolate reductase and lactate dehydrogenase, enzymes which use NADH as a substrate. Biochem. Biophys. Res. Commun., 2015, 465(3), 363-367.
[http://dx.doi.org/10.1016/j.bbrc.2015.08.004]
[103]
Granchi, C.; Roy, S.; Mottinelli, M.; Nardini, E.; Campinoti, F.; Tuccinardi, T.; Lanza, M.; Betti, L.; Giannaccini, G.; Lucacchini, A.; Martinelli, A.; Macchia, M.; Minutolo, F. Synthesis of sulfonamide-containing N-hydroxyindole-2-carboxylates as inhibitors of human lactate dehydrogenase-isoform 5. Bioorg. Med. Chem. Lett., 2011, 21(24), 7331-7336.
[http://dx.doi.org/10.1016/j.bmcl.2011.10.031]
[104]
Manerba, M.; Di Ianni, L.; Fiume, L.; Roberti, M.; Recanatini, M.; Di Stefano, G. Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. Eur. J. Pharm. Sci., 2015, 74, 95-102.
[http://dx.doi.org/10.1016/j.ejps.2015.04.022]
[105]
Le, A.; Cooper, C.R.; Gouw, A.M.; Dinavahi, R.; Maitra, A.; Deck, L.M.; Royer, R.E.; Vander Jagt, D.L.; Semenza, G.L.; Dang, C.V. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. USA, 2010, 107(5), 2037-2042.
[http://dx.doi.org/10.1073/pnas.0914433107]
[106]
Hasmann, M.; Schemainda, I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res., 2003, 63(21), 7436-7442.
[107]
Kim, E.Y.; Chung, T.W.; Han, C.W.; Park, S.Y.; Park, K.H.; Jang, S.B.; Ha, K.T. A novel lactate dehydrogenase inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death. Sci. Rep., 2019, 9(1), 3969.
[http://dx.doi.org/10.1038/s41598-019-40617-3]
[108]
Granchi, C.; Roy, S.; De Simone, A.; Salvetti, I.; Tuccinardi, T.; Martinelli, A.; Macchia, M.; Lanza, M.; Betti, L.; Giannaccini, G.; Lucacchini, A.; Giovannetti, E.; Sciarrillo, R.; Peters, G.J.; Minutolo, F. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation. Eur. J. Med. Chem., 2011, 46(11), 5398-5407.
[http://dx.doi.org/10.1016/j.ejmech.2011.08.046]
[109]
Seth, P.; Grant, A.; Tang, J.; Vinogradov, E.; Wang, X.; Lenkinski, R.; Sukhatme, V.P. On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. Neoplasia, 2011, 13(1), 60-71.
[http://dx.doi.org/10.1593/neo.101020]
[110]
Koukourakis, M.I.; Giatromanolaki, A.; Simopoulos, C.; Polychronidis, A.; Sivridis, E. Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin. Exp. Metastasis, 2005, 22(1), 25-30.
[http://dx.doi.org/10.1007/s10585-005-2343-7]
[111]
Draoui, N.; Feron, O. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments. Dis. Model. Mech., 2011, 4(6), 727-732.
[http://dx.doi.org/10.1242/dmm.007724]
[112]
Bongaerts, G.; Wagener, T. High aerobic glycolysis in cancers: What does it mean? Nat. Rev. Cancer, 2005, 5, 412.
[http://dx.doi.org/10.1038/nrc1478-c1]
[113]
Gatenby, R.A.; Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer, 2004, 4(11), 891-899.
[http://dx.doi.org/10.1038/nrc1478]
[114]
Kim, J.W.; Dang, C.V. Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res., 2006, 66(18), 8927-8930.
[http://dx.doi.org/10.1158/0008-5472.CAN-06-1501]
[115]
Koukourakis, M.I.; Giatromanolaki, A.; Sivridis, E. Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol., 2003, 24(4), 199-202.
[http://dx.doi.org/10.1159/000074430]
[116]
Koukourakis, M.I.; Kontomanolis, E.; Giatromanolaki, A.; Sivridis, E.; Liberis, V. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol. Obstet. Invest., 2009, 67(3), 162-168.
[http://dx.doi.org/10.1159/000183250]
[117]
Boussouar, F.; Benahmed, M. Epidermal growth factor regulates glucose metabolism through lactate dehydrogenase A messenger ribonucleic acid expression in cultured porcine Sertoli cells. Biol. Reprod., 1999, 61(4), 1139-1145.
[http://dx.doi.org/10.1095/biolreprod61.4.1139]
[118]
Shim, H.; Dolde, C.; Lewis, B.C.; Wu, C.S.; Dang, G.; Jungmann, R.A.; Dalla-Favera, R.; Dang, C.V. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA, 1997, 94(13), 6658-6663.
[http://dx.doi.org/10.1073/pnas.94.13.6658]
[119]
Dang, C.V. Links between metabolism and cancer. Genes Dev., 2012, 26(9), 877-890.
[http://dx.doi.org/10.1101/gad.189365.112]
[120]
Zhong, H.; De Marzo, A.M.; Laughner, E.; Lim, M.; Hilton, D.A.; Zagzag, D.; Buechler, P.; Isaacs, W.B.; Semenza, G.L.; Simons, J.W. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res., 1999, 59(22), 5830-5835.
[121]
Kolev, Y.; Uetake, H.; Takagi, Y.; Sugihara, K. Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann. Surg. Oncol., 2008, 15(8), 2336-2344.
[http://dx.doi.org/10.1245/s10434-008-9955-5]
[122]
Leiblich, A.; Cross, S.S.; Catto, J.W.F.; Phillips, J.T.; Leung, H.Y.; Hamdy, F.C.; Rehman, I. Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer. Oncogene, 2006, 25(20), 2953-2960.
[http://dx.doi.org/10.1038/sj.onc.1209262]
[123]
Liao, A.C.; Li, C.F.; Shen, K.H.; Chien, L.H.; Huang, H.Y.; Wu, T.F. Loss of lactate dehydrogenase B subunit expression is correlated with tumour progression and independently predicts inferior disease-specific survival in urinary bladder urothelial carcinoma. Pathology, 2011, 43(7), 707-712.
[http://dx.doi.org/10.1097/PAT.0b013e32834bf67a]
[124]
Fan, J.; Hitosugi, T.; Chung, T-W.; Xie, J.; Ge, Q.; Gu, T-L.; Polakiewicz, R.D.; Chen, G.Z.; Boggon, T.J.; Lonial, S.; Khuri, F.R.; Kang, S.; Chen, J. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells. Mol. Cell. Biol., 2011, 31(24), 4938-4950.
[http://dx.doi.org/10.1128/MCB.06120-11]
[125]
Zhao, D.; Zou, S.W.; Liu, Y.; Zhou, X.; Mo, Y.; Wang, P.; Xu, Y.H.; Dong, B.; Xiong, Y.; Lei, Q.Y.; Guan, K.L. Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Cancer Cell, 2013, 23(4), 464-476.
[http://dx.doi.org/10.1016/j.ccr.2013.02.005]
[126]
Xie, H.; Valera, V.A.; Merino, M.J.; Amato, A.M.; Signoretti, S.; Linehan, W.M.; Sukhatme, V.P.; Seth, P. LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol. Cancer Ther., 2009, 8(3), 626-635.
[http://dx.doi.org/10.1158/1535-7163.MCT-08-1049]
[127]
Liu, Y.; Guo, J.Z.; Liu, Y.; Wang, K.; Ding, W.; Wang, H.; Liu, X.; Zhou, S.; Lu, X.C.; Yang, H.B.; Xu, C.; Gao, W.; Zhou, L.; Wang, Y.P.; Hu, W.; Wei, Y.; Huang, C.; Lei, Q.Y. Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth. Nat. Commun., 2018, 9(1), 4429.
[http://dx.doi.org/10.1038/s41467-018-06841-7]
[128]
Maekawa, M.; Inomata, M.; Sasaki, M.S.; Kaneko, A.; Ushiama, M.; Sugano, K.; Takayama, J.; Kanno, T. Electrophoretic variant of a lactate dehydrogenase isoenzyme and selective promoter methylation of the LDHA gene in a human retinoblastoma cell line. Clin. Chem., 2002, 48(11), 1938-1945.
[129]
Kumar, P.; Nagarajan, A.; Uchil, P.D. Analysis of cell viability by the alamar Blue assay., 2018.
[130]
Kimble-Hill, A.C.; Younus, H.; Meroueh, S.; Hurley, T.D. Structure based inhibition of mitochondrial aldehyde dehydrogenase (ALDH2) activity. Biophys. J., 2011, 100, 215.
[http://dx.doi.org/10.1016/j.bpj.2010.12.1387]
[131]
Laskar, A.A.; Alam, M.F.; Ahmad, M.; Younus, H. Kinetic and biophysical investigation of the inhibitory effect of caffeine on human salivary aldehyde dehydrogenase: Implications in oral health and chemotherapy. J. Mol. Struct., 2018, 1157, 61-68.
[http://dx.doi.org/10.1016/j.molstruc.2017.12.050]
[132]
Sabouni, F.; Siadati, A.; Farpoor, S.; Sabouni, F. Elevated serum lactate dehydrogenase values in children with multiorgan involvements and severe febrile illness. Iran J. Ped. Soc., 2007, 1, 31-35.
[133]
Miao, P.; Sheng, S.; Sun, X.; Liu, J.; Huang, G. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life, 2013, 65(11), 904-910.
[http://dx.doi.org/10.1002/iub.1216]
[134]
Yun, S.J.; Choi, M.S.; Piao, M.S.; Lee, J.B.; Kim, S.J.; Won, Y.H.; Lee, S.C. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis. Dermatology (Basel), 2008, 217(3), 254-259.
[http://dx.doi.org/10.1159/000148255]
[135]
González-Billalabeitia, E.; Hitt, R.; Fernández, J.; Conde, E.; Martínez-Tello, F.; Enríquez de Salamanca, R.; Cortés-Funes, H. Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma. Clin. Transl. Oncol., 2009, 11(7), 479-483.
[http://dx.doi.org/10.1007/s12094-009-0388-9]
[136]
Thomas, L. Laktat-Dehydrogenase (LDH) 2-Hydroxybutyrat-Dehydrogenase (HBDH) in Labor und Diagnose- Indikation und Bewertung yon Laborbefundenfiir die medizinische Diagnostik Die Medizinische Verlagsgesellschaft Marburg 4; Auflage, 1992, p. 136.
[137]
Yu, Y.; Liao, M.; Liu, R.; Chen, J.; Feng, H.; Fu, Z. Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: its implication for treatment. World J. Surg. Oncol., 2014, 12, 78.
[http://dx.doi.org/10.1186/1477-7819-12-78]
[138]
Yao, F.; Zhao, T.; Zhong, C.; Zhu, J.; Zhao, H. LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma. Tumour Biol., 2013, 34(1), 25-31.
[http://dx.doi.org/10.1007/s13277-012-0506-0]
[139]
Cai, Z.; Zhao, J.S.; Li, J.J.; Peng, D.N.; Wang, X.Y.; Chen, T.L.; Qiu, Y.P.; Chen, P.P.; Li, W.J.; Xu, L.Y.; Li, E.M.; Tam, J.P.; Qi, R.Z.; Jia, W.; Xie, D. A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol. Cell. Proteomics, 2010, 9(12), 2617-2628.
[http://dx.doi.org/10.1074/mcp.M110.000661]
[140]
Slamon, D.J.; Godolphin, W.; Jones, L.A.; Holt, J.A.; Wong, S.G.; Keith, D.E.; Levin, W.J.; Stuart, S.G.; Udove, J.; Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 1989, 244(4905), 707-712.
[http://dx.doi.org/10.1126/science.2470152]
[141]
Zhao, Y.H.; Zhou, M.; Liu, H.; Ding, Y.; Khong, H.T.; Yu, D.; Fodstad, O.; Tan, M. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene, 2009, 28(42), 3689-3701.
[http://dx.doi.org/10.1038/onc.2009.229]
[142]
Agrawal, A.; Gandhe, M.B.; Gupta, D.; Reddy, M.V. Preliminary Study on Serum Lactate Dehydrogenase (LDH)-Prognostic Biomarker in Carcinoma Breast. J. Clin. Diagn. Res., 2016, 10(3), BC06-BC08.
[http://dx.doi.org/10.7860/JCDR/2016/17111.7364]
[143]
Nagai, M.A.; Sonohara, S.; Brentani, M.M. Estrogen control of lactate dehydrogenase isoenzyme-5 in human breast cancer. Int. J. Cancer, 1988, 41(1), 10-16.
[http://dx.doi.org/10.1002/ijc.2910410104]
[144]
Thomas, M.; Monet, J.D.; Brami, M.; Dautigny, N.; Assailly, J.; Ulmann, A.; Bader, C.A. Comparative effects of 17 beta-estradiol, progestin R5020, tamoxifen and RU38486 on lactate dehydrogenase activity in MCF-7 human breast cancer cells. J. Steroid Biochem., 1989, 32(2), 271-277.
[http://dx.doi.org/10.1016/0022-4731(89)90263-X]
[145]
Seth, L.R.; Kharb, S.; Kharb, D.P. Serum biochemical markers in carcinoma breast. Indian J. Med. Sci., 2003, 57(8), 350-354.
[146]
Mehreen, L.; Khanam, A. Evaluation of toxicities induced by chemotherapy in breast cancer patients. Biomed. Pharmacother., 2005, 59(9), 524-527.
[http://dx.doi.org/10.1016/j.biopha.2004.12.002]
[147]
Kales, C.P.; Murren, J.R.; Torres, R.A.; Crocco, J.A. Early predictors of in-hospital mortality for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Arch. Intern. Med., 1987, 147(8), 1413-1417.
[http://dx.doi.org/10.1001/archinte.1987.00370080049012]
[148]
Sevinc, A.; Sari, R.; Fadillioglu, E. The utility of lactate dehydrogenase isoenzyme pattern in the diagnostic evaluation of malignant and nonmalignant ascites. J. Natl. Med. Assoc., 2005, 97(1), 79-84.
[149]
Lossos, I.S.; Breuer, R.; Intrator, O.; Sonenblick, M. Differential diagnosis of pleural effusion by lactate dehydrogenase isoenzyme analysis. Chest, 1997, 111(3), 648-651.
[http://dx.doi.org/10.1378/chest.111.3.648]
[150]
O’Brien, R.F. In search of shortcuts: definitive and indirect tests in the diagnosis of Pneumocystis carinii pneumonia in AIDS. Am. Rev. Respir. Dis., 1989, 139(6), 1324-1327.
[http://dx.doi.org/10.1164/ajrccm/139.6.1324]
[151]
Holz, O.; Jorres, R.A.; Koschyk, S.; Speckin, P.; Welker, L.; Magnussen, H. Changes of Cellular and Biochemical Sputum Composition During Sputum Induction in Healthy and Asthmatic Subjects. American Acad Allergy Asthma Immuno. Abstract Conference, 1996.New Orleans, USA
[152]
Luo, F.M.; Liu, C.T.; Li, S.Q.; Wang, Z.L. Simvastatin induces eosinophil apoptosis in vitro. Zhonghua Jie He He Hu Xi Za Zhi, 2005, 28(5), 320-323.
[153]
Verma, P.; Biswas, S.; Mohan, T.; Ali, S.; Rao, D.N. Detection of histidine rich protein & lactate dehydrogenase of Plasmodium falciparum in malaria patients by sandwich ELISA using in-house reagents. Indian J. Med. Res., 2013, 138(6), 977-987.
[154]
Vander Jagt, D.L.; Hunsaker, L.A.; Campos, N.M.; Baack, B.R. D-lactate production in erythrocytes infected with Plasmodium falciparum. Mol. Biochem. Parasitol., 1990, 42(2), 277-284.
[http://dx.doi.org/10.1016/0166-6851(90)90171-H]
[155]
Makler, M.T.; Hinrichs, D.J. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am. J. Trop. Med. Hyg., 1993, 48(2), 205-210.
[http://dx.doi.org/10.4269/ajtmh.1993.48.205]
[156]
Piper, R.; Lebras, J.; Wentworth, L.; Hunt-Cooke, A.; Houzé, S.; Chiodini, P.; Makler, M. Immunocapture diagnostic assays for malaria using Plasmodium lactate dehydrogenase (pLDH). Am. J. Trop. Med. Hyg., 1999, 60(1), 109-118.
[http://dx.doi.org/10.4269/ajtmh.1999.60.109]
[157]
Brown, W.M.; Yowell, C.A.; Hoard, A.; Vander Jagt, T.A.; Hunsaker, L.A.; Deck, L.M.; Royer, R.E.; Piper, R.C.; Dame, J.B.; Makler, M.T.; Vander Jagt, D.L. Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites. Biochemistry, 2004, 43(20), 6219-6229.
[http://dx.doi.org/10.1021/bi049892w]
[158]
Griffiths, P.D. Serum enzymes in diseases of the thyroid gland. J. Clin. Pathol., 1965, 18(5), 660-663.
[http://dx.doi.org/10.1136/jcp.18.5.660]
[159]
Fleisher, G.A.; McConahey, W.M.; Pankow, M. Serum creatine kinase lactic dehydrogenase and glutamicoxaloacetic transaminase in thyroid diseases and pregnancy. Mayo Clin. Proc., 1965, 40, 300-311.
[160]
McGrowder, D.A.; Fraser, Y.P.; Gordon, L.; Crawford, T.V.; Rawlins, J.M. Serum creatine kinase and lactate dehydrogenase activities in patients with thyroid disorders. Niger. J. Clin. Pract., 2011, 14(4), 454-459.
[http://dx.doi.org/10.4103/1119-3077.91755]
[161]
Nussinovitch, M.; Finkelstein, Y.; Elishkevitz, K.P.; Volovitz, B.; Harel, D.; Klinger, G.; Razon, Y.; Nussinovitch, U.; Nussinovitch, N. Cerebrospinal fluid lactate dehydrogenase isoenzymes in children with bacterial and aseptic meningitis. Transl. Res., 2009, 154(4), 214-218.
[http://dx.doi.org/10.1016/j.trsl.2009.06.011]
[162]
Kamat, D.V.; Chakravorty, B.P. Comparative values of CSF-LDH isoenzymes in neurological disorders. Indian J. Med. Sci., 1999, 53(1), 1-6.
[163]
Feldman, W.E. Cerebrospinal fluid lactic acid dehydrogenase activity. Levels in untreated and partially antibiotic-treated meningitis. Am. J. Dis. Child., 1975, 129(1), 77-80.
[http://dx.doi.org/10.1001/archpedi.1975.02120380053012]
[164]
Jaiswar, S.P.; Gupta, A.; Sachan, R.; Natu, S.N.; Shaili, M. Lactic dehydrogenase: A biochemical marker for preeclampsia-eclampsia. J. Obstet. Gynaecol. India, 2011, 61(6), 645-648.
[http://dx.doi.org/10.1007/s13224-011-0093-9]
[165]
Kant, R.H.; Mir, N.; Sarwar, S.; Gupta, S.; Najeeb, R. Role of maternal serum lactate dehydrogenase as a biochemical marker in pre-eclampsia. IOSR J Dental Med Sci, 2015, 14, 12-19.
[166]
Miotti, A.B.; Alter, A.A.; Moltz, A.; Sabb, F. Serum and amniotic fluid lactic dehydrogenase in pregnant women. Am. J. Obstet. Gynecol., 1973, 117(8), 1129-1136.
[http://dx.doi.org/10.1016/0002-9378(73)90764-3]
[167]
Boldt, M.J.; Bai, T.R. Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia. Chest, 1997, 111(5), 1187-1192.
[http://dx.doi.org/10.1378/chest.111.5.1187]
[168]
Meeker, D.P.; Matysik, G.A.; Stelmach, K.; Rehm, S. Diagnostic utility of lactate dehydrogenase levels in patients receiving aerosolized pentamidine. Chest, 1993, 104(2), 386-388.
[http://dx.doi.org/10.1378/chest.104.2.386]
[169]
Butt, A.A.; Patterson, T.F.; Figueroa, J.E.; Steele, R.W. Skin lesions and pulmonary infiltrates in a patient with AIDS. Infect. Med., 1997, 14, 596-600.
[170]
Corcoran, G.R.; Al-Abdely, H.; Flanders, C.D.; Geimer, J.; Patterson, T.F. Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS. Clin. Infect. Dis., 1997, 24(5), 942-944.
[http://dx.doi.org/10.1093/clinids/24.5.942]
[171]
Pugin, J.; Vanhems, P.; Hirschel, B.; Chave, J.P.; Flepp, M. Extreme elevations of serum lactic dehydrogenase differentiating pulmonary toxoplasmosis from Pneumocystis pneumonia. N. Engl. J. Med., 1992, 326(18), 1226.
[http://dx.doi.org/10.1056/NEJM199204303261815]
[172]
Lucet, J.C.; Bailly, M.P.; Bedos, J.P.; Wolff, M.; Gachot, B.; Vachon, F. Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus. Chest, 1993, 104(4), 1054-1058.
[http://dx.doi.org/10.1378/chest.104.4.1054]
[173]
Vaccher, E.; Tirelli, U.; Spina, M.; Talamini, R.; Errante, D.; Simonelli, C.; Carbone, A. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin’s lymphomas: A single-institute study of 96 patients. J. Clin. Oncol., 1996, 14(8), 2217-2223.
[http://dx.doi.org/10.1200/JCO.1996.14.8.2217]
[174]
Hagemeister, F.B.; Khetan, R.; Allen, P.; McLaughlin, P.; Rodriguez, M.A.; Swan, F., Jr; Romaguera, J.E.; Cabanillas, F. Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. Ann. Oncol., 1994, 5(Suppl. 2), 41-46.
[http://dx.doi.org/10.1093/annonc/5.suppl_2.S41]
[175]
Houki, N.; Matsushima, Y.; Kitamura, M.; Tukada, T.; Nishina, T.; Nakayama, T. A case of deficiency of lactate dehydrogenase H-subunit. Jap. J. Clin. Chem., 1986, 15, 85-90.
[176]
Joukyuu, R.; Mizuno, S.; Amakawa, T.; Tsukada, T.; Nishina, T.; Kitamura, M. Hereditary complete deficiency of lactate dehydrogenase H-subunit. Clin. Chem., 1989, 35(4), 687-690.
[177]
Kanno, T.; Sudo, K.; Maekawa, M.; Nishimura, Y.; Ukita, M.; Fukutake, K. Lactate dehydrogenase M-subunit deficiency: A new type of hereditary exertional myopathy. Clin. Chim. Acta, 1988, 173(1), 89-98.
[http://dx.doi.org/10.1016/0009-8981(88)90359-2]
[178]
Kanno, T.; Sudo, K.; Kitamura, M.; Miwa, S.; Ichiyama, A.; Nishimura, Y. Lactate dehydrogenase A-subunit and B-subunit deficiencies: comparison of the physiological roles of LDH isozymes. Isozymes Curr. Top. Biol. Med. Res., 1983, 7, 131-150.
[179]
Kanno, T.; Sudo, K.; Takeuchi, I.; Kanda, S.; Honda, N.; Nishimura, Y.; Oyama, K. Hereditary deficiency of lactate dehydrogenase M-subunit. Clin. Chim. Acta, 1980, 108(2), 267-276.
[http://dx.doi.org/10.1016/0009-8981(80)90013-3]
[180]
Nishirnura, Y.; Honda, N.; Ohyarna, K.; Ichiyama, A.; Yanagisawa, M.; Sudo, K.; Kanno, T. Isozymes Current Topics in Biological and Medical Research. Rattazzi M.C, Scandalios J.G, Whitt G.S; Liss, A.R., Ed.; Inc New York, 1983, Vol. 11, pp. 51-64.

Rights & Permissions Print Cite
Article Metrics
160
5
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy